Novartis (NOVN.S.), based in Switzerland, announced on Tuesday that it is increasing its profit prediction for the entire year for…
novartis
Novartis (NOVN.S) will buy Seattle company Chinook Therapeutics (KDNY.O) for up to $3.5 billion to add a rare severe kidney…
Sandoz, the generics branch of Novartis (NOVN.S), will be spun off soon, and the Swiss company said Thursday that it…
Novartis (NOVN.S) announced the new Sandoz board members on Monday. The Basel corporation accepted Sandoz Chairman-designate Gilbert Ghostine’s ten board…
After a breast cancer medication trial success and the development of a prostate cancer radiation medicine, Novartis (NOVN.S) boosted its…
Google announced Tuesday, July 15, that they will develop and produce contact lenses that could potentially measure wearers’ blood sugar…
